A Prospective Real World Study of Rimegepant in the Treatment of Migraine
NCT05709106
·
clinicaltrials.gov ↗
COMPLETED
Status
173
Enrollment
OTHER
Sponsor class
Conditions
Migraine
Interventions
DRUG:
Rimegepant 75 MG
Sponsor
Ruijin-Hainan Hospital Shanghai Jiao Tong University School Of Medicine